Guidance for providers offering medical abortion with misoprostol during COVID-19

With COVID-19 shifting access to safe abortion services, Gynuity Health Projects and CEDES, in collaboration with ASAP, CLACAI, REDAAS and Women Help Women, have developed a resource to support providers to administer misoprostol for a medical abortion safely during the COVID-19 pandemic, and in accordance with social distancing recommendations.

The guidance reviews the steps of providing misoprostol medical abortion and makes evidence-based recommendations for limiting contact and reducing in-person visits.

The resource is currently available on CEDES’ and Gynuity’s websites in English, Spanish, French, Portuguese and Russian in both PDF and mobile format.

Visit Gynuity’s website to download the guides.